Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

Metastatic clear cell renal cell carcinoma (mccRCC) benefits from several treatment options in the first-line setting with VEGFR inhibitors and/or immunotherapy including anti-PD-L1 or anti-PD1 agents. Identification of predictive biomarkers is highly needed to optimize patient care. Circulating mar...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Montemagno, Christopher, Hagege, Anais, Borchiellini, Delphine, Thamphya, Brice, Rastoin, Olivia, Ambrosetti, Damien, Iovanna, Juan, Rioux-Leclercq, Nathalie, Porta, Camillio, Negrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Pagès, Gilles, Dufies, Maeva
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7714499/
https://ncbi.nlm.nih.gov/pubmed/33299657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1846901
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi